{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:26:52Z","timestamp":1793654812371,"version":"4.5.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"crossref","award":["ADMIRE BM1301"],"award-info":[{"award-number":["ADMIRE BM1301"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"crossref","award":["ENSAT-HT 633983"],"award-info":[{"award-number":["ENSAT-HT 633983"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Societ\u00e0 Italiana dell\u2019Ipertensione Arteriosa"},{"name":"FORICA"},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40292-020-00415-9","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T21:03:17Z","timestamp":1604955797000},"page":"547-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-8033","authenticated-orcid":false,"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bisogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Rossitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Maria","family":"Seccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J."},{"key":"415_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2007.01.119","volume":"124","author":"JR Chiong","year":"2008","unstructured":"Chiong JR, Aronow WS, Khan IA, Nair CK, Vijayaraghavan K, Dart RA, et al. Secondary hypertension: current diagnosis and treatment. Int J Cardiol. 2008;124:6\u201321.","journal-title":"Int J Cardiol."},{"key":"415_CR3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","volume":"385","author":"M Azizi","year":"2015","unstructured":"Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957\u201365.","journal-title":"Lancet"},{"key":"415_CR4","doi-asserted-by":"crossref","unstructured":"Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, et al. Prevalence and outcome of drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling. Eur J Prev Cardiol. 2020. (In press).","DOI":"10.1093\/eurjpc\/zwaa108"},{"key":"415_CR5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/157016110793563843","volume":"8","author":"GP Rossi","year":"2010","unstructured":"Rossi GP, Seccia TM, Pessina AC. Secondary hypertension: the ways of management. Curr Vasc Pharmacol. 2010;8:753\u201368.","journal-title":"Curr Vasc Pharmacol."},{"key":"415_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11936-019-0790-8","volume":"21","author":"JS Hirsch","year":"2019","unstructured":"Hirsch JS, Hong S. The demystification of secondary hypertension: diagnostic strategies and treatment algorithms. Curr Treat Options Cardiovasc Med. 2019;21:90.","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","volume":"35","author":"SF Rimoldi","year":"2014","unstructured":"Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35:1245\u201354.","journal-title":"Eur Heart J."},{"key":"415_CR8","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro M-C, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism. J Hypertens. 2020. (Online ahead of print)."},{"key":"415_CR9","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP. Primary aldosteronism: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:2799\u2013811.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892\u20136.","journal-title":"Hypertension"},{"key":"415_CR13","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(08)61867-X","volume":"372","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;372:2022.","journal-title":"Lancet"},{"key":"415_CR14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, et al. Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension. 2018;72:874\u201380.","journal-title":"Hypertension"},{"key":"415_CR15","doi-asserted-by":"crossref","first-page":"017","DOI":"10.1210\/clinem\/dgz017","volume":"105","author":"G Rossitto","year":"2020","unstructured":"Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, et al. Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization. J Clin Endocrinol Metab. 2020;105:017.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","volume":"12","author":"TM Seccia","year":"2005","unstructured":"Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn\u2019s syndrome with an ominous clinical course. Endocr Relat Cancer. 2005;12:149\u201359.","journal-title":"Endocr Relat Cancer."},{"key":"415_CR17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/HYPERTENSIONAHA.118.11150","volume":"71","author":"L Lenzini","year":"2018","unstructured":"Lenzini L, Prisco S, Caroccia B, Rossi GP. Saga of familial hyperaldosteronism yet a new channel. Hypertension. 2018;71:1010\u20134.","journal-title":"Hypertension"},{"key":"415_CR18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med. 1981;141:1589\u201393.","journal-title":"Arch Intern Med."},{"key":"415_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/HJH.0000000000000892","volume":"34","author":"GP Rossi","year":"2016","unstructured":"Rossi GP, Bisogni V. A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)-App. J Hypertens. 2016;34:1019\u201321.","journal-title":"J Hypertens."},{"key":"415_CR20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2016-3821","volume":"102","author":"AH Ahmed","year":"2017","unstructured":"Ahmed AH, Gordon RD, Ward G, Wolley M, McWhinney BC, Ungerer JP, et al. Effect of moxonidine on the aldosterone\/renin ratio in healthy male volunteers. J Clin Endocrinol Metab. 2017;102:2039\u201343.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR21","doi-asserted-by":"crossref","first-page":"dgaa080","DOI":"10.1210\/clinem\/dgaa080","volume":"105","author":"GP Rossi","year":"2020","unstructured":"Rossi GP, Ceolotto G, Rossitto G, Maiolino G, Cesari M, Seccia TM. Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone\u2013renin ratio in primary aldosteronism\u2014the EMIRA study. J Clin Endocrinol Metab. 2020;105:dgaa080.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","volume":"104","author":"AT Nanba","year":"2018","unstructured":"Nanba AT, Wannachalee T, Shields JJ, Byrd JB, Rainey WE, Auchus RJ, et al. Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism. J Clin Endocrinol Metab. 2018;104:487\u201392.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR23","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","volume":"99","author":"M Haase","year":"2014","unstructured":"Haase M, Riester A, Kr\u00f6pil P, Hahner S, Degenhart C, Willenberg HS, et al. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy. J Clin Endocrinol Metab. 2014;99:4397\u2013402.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"JB Byrd","year":"2018","unstructured":"Byrd JB, Turcu AF, Auchus RJ. Primary aldosteronism: practical approach to diagnosis and management. Circulation. 2018;138:823\u201335.","journal-title":"Circulation"},{"key":"415_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1309\/8EXCCM6YR1THUBAF","volume":"119","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Toward complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Am J Clin Pathol. 2003;119:18\u201322.","journal-title":"Am J Clin Pathol."},{"key":"415_CR26","doi-asserted-by":"crossref","first-page":"e005574","DOI":"10.1161\/JAHA.117.005574","volume":"6","author":"G Maiolino","year":"2017","unstructured":"Maiolino G, Rossitto G, Bisogni V, Cesari M, Seccia TM, Plebani M, et al. Quantitative value of aldosterone\u2013renin ratio for detection of aldosterone-producing adenoma: the Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study. J Am Heart Assoc. 2017;6:e005574.","journal-title":"J Am Heart Assoc."},{"key":"415_CR27","doi-asserted-by":"crossref","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","DOI":"10.1210\/jc.2015-4061"},{"key":"415_CR28","doi-asserted-by":"crossref","first-page":"1000292","DOI":"10.1016\/j.ijchy.2020.100029","volume":"5","author":"GP Rossi","year":"2020","unstructured":"Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistr\u00e8 A, et al. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:1000292.","journal-title":"Int J Cardiol Hypertens."},{"key":"415_CR29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, et al. Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension. 2019;74:800\u20138.","journal-title":"Hypertension"},{"key":"415_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51\u20139.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"415_CR31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1358863X18821816","volume":"24","author":"HL Gornik","year":"2019","unstructured":"Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med (United Kingdom). 2019;24:164\u201389.","journal-title":"Vasc Med (United Kingdom)."},{"key":"415_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/cs0930435","volume":"93","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Pavan E, Chiesura-Corona M, Bader M, Paganini G, Cesari M, et al. Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features. Clin Sci. 1997;93:435\u201343.","journal-title":"Clin Sci."},{"key":"415_CR33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC\/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery. J Am Coll Cardiol. 2006;47:1239\u2013312.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jcin.2018.10.023","volume":"12","author":"M Prince","year":"2019","unstructured":"Prince M, Tafur JD, White CJ. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC Cardiovasc Interv. 2019;12:505\u201317.","journal-title":"JACC Cardiovasc Interv"},{"key":"415_CR35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jacc.2018.10.002","volume":"73","author":"SR Bailey","year":"2019","unstructured":"Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, et al. ACC\/AHA\/SCAI\/SIR\/SVM 2018 appropriate use criteria for peripheral artery intervention: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2019;73:214\u201337.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR36","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915\u201342.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","volume":"141","author":"M Mannelli","year":"1999","unstructured":"Mannelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol. 1999;141:619\u201324.","journal-title":"Eur J Endocrinol."},{"key":"415_CR38","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, et al. Genetics, diagnosis, management and future directions of research of pheochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1443\u201356.","journal-title":"J Hypertens."},{"key":"415_CR39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:1526\u201340.","journal-title":"J Clin Endocrinol Metab."},{"key":"415_CR40","first-page":"281","volume":"7","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA. Cushing\u2019s syndrome: Epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281\u201393.","journal-title":"Clin Epidemiol."},{"key":"415_CR41","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.4103\/2230-8210.86973","volume":"15","author":"Y Singh","year":"2011","unstructured":"Singh Y, Menon A, Kotwal N. Endocrine hypertension\u2014Cushing\u2019s syndrome. Indian J Endocrinol Metab. 2011;15:S313\u20136.","journal-title":"Indian J Endocrinol Metab."},{"key":"415_CR42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2019.00321","volume":"10","author":"M Barbot","year":"2019","unstructured":"Barbot M, Ceccato F, Scaroni C. The pathophysiology and treatment of hypertension in patients with Cushing\u2019s syndrome. Front Endocrinol (Lausanne). 2019;10:321.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"415_CR43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378\u201384.","journal-title":"N Engl J Med."},{"key":"415_CR44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1378\/chest.13-0085","volume":"144","author":"RP Pedrosa","year":"2013","unstructured":"Pedrosa RP, Drager LF, De Paula LKG, Amaro ACS, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest. 2013;144:1487\u201394.","journal-title":"Chest"},{"key":"415_CR45","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-0043-122887","volume":"49","author":"A Prejbisz","year":"2017","unstructured":"Prejbisz A, Ko\u0142odziejczyk-Kruk S, Lenders JWM, Januszewicz A. Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship? Horm Metab Res. 2017;49:969\u201376.","journal-title":"Horm Metab Res."},{"key":"415_CR46","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","volume":"74","author":"F Buffolo","year":"2019","unstructured":"Buffolo F, Li Q, Monticone S, Heinrich DA, Mattei A, Pieroni J, et al. Primary aldosteronism and obstructive sleep apnea a cross-sectional multi-ethnic study. Hypertension. 2019;74:1532\u201340.","journal-title":"Hypertension"},{"key":"415_CR47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.00226711","volume":"41","author":"G Parati","year":"2013","unstructured":"Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Recommendations for the management of patients with obstructive sleep apnea and hypertension. Eur Respir J. 2013;41:523\u201338.","journal-title":"Eur Respir J."},{"key":"415_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","volume":"5","author":"LJ Epstein","year":"2009","unstructured":"Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5:263\u201376.","journal-title":"J Clin Sleep Med."},{"key":"415_CR49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","volume":"13","author":"VK Kapur","year":"2017","unstructured":"Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479\u2013504.","journal-title":"J Clin Sleep Med."},{"key":"415_CR50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/coa.13213","volume":"43","author":"A De Vito","year":"2018","unstructured":"De Vito A, Carrasco Llatas M, Ravesloot MJ, Kotecha B, De Vries N, Hamans E, et al. European position paper on drug-induced sleep endoscopy: 2017 update. Clin Otolaryngol. 2018;43:1541\u201352.","journal-title":"Clin Otolaryngol."},{"key":"415_CR51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5664\/jcsm.7638","volume":"15","author":"SP Patil","year":"2019","unstructured":"Patil SP, Ayappa IA, Caples SM, John Kimoff R, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of sleep medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019;15:301\u201334.","journal-title":"J Clin Sleep Med."},{"key":"415_CR52","first-page":"243","volume":"8","author":"V Bisogni","year":"2016","unstructured":"Bisogni V, Pengo MF, Maiolino G, Rossi GP. The sympathetic nervous system and catechol amines metabolism in obstructive sleep apnea. J Thorac Dis. 2016;8:243\u201354.","journal-title":"J Thorac Dis."},{"key":"415_CR53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201403-0526OC","volume":"190","author":"DDM Nicholl","year":"2014","unstructured":"Nicholl DDM, Hanly PJ, Poulin MJ, Handley GB, Hemmelgarn BR, Sola DY, et al. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190:572\u201380.","journal-title":"Am J Respir Crit Care Med."},{"key":"415_CR54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archinte.167.8.757","volume":"16","author":"P Haentjens","year":"2007","unstructured":"Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;16:757\u201364.","journal-title":"Arch Intern Med."},{"key":"415_CR55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","volume":"69","author":"S Javaheri","year":"2017","unstructured":"Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841\u201358.","journal-title":"J Am Coll Cardiol."},{"key":"415_CR56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/thoraxjnl-2013-204993","volume":"69","author":"DJ Bratton","year":"2014","unstructured":"Bratton DJ, Stradling JR, Barb\u00e9 F, Kohler M. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax. 2014;69:1128\u201335.","journal-title":"Thorax"},{"key":"415_CR57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1378\/chest.13-1115","volume":"145","author":"C Fava","year":"2014","unstructured":"Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, et al. Effect of CPAP on blood pressure in patients with OSA\/hypopnea: a systematic review and meta-analysis. Chest. 2014;145:762\u201371.","journal-title":"Chest"},{"key":"415_CR58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5664\/jcsm.3604","volume":"10","author":"JP Bakker","year":"2014","unstructured":"Bakker JP, Edwards BA, Gautam SP, Montesi SB, Dur\u00e1n-Cantolla J, Barandiar\u00e1n FA, et al. Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity. J Clin Sleep Med. 2014;10:365\u20139.","journal-title":"J Clin Sleep Med."},{"key":"415_CR59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41440-020-0468-3","volume":"43","author":"S Morimoto","year":"2020","unstructured":"Morimoto S, Ichihara A. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension. Hypertens Res. 2020;43:744\u201353.","journal-title":"Hypertens Res"},{"key":"415_CR60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.15-0136","volume":"148","author":"G Torres","year":"2015","unstructured":"Torres G, S\u00e1nchez-De-La-Torre M, Barb\u00e9 F. Relationship between OSA and hypertension. Chest. 2015;148:824\u201332.","journal-title":"Chest"},{"key":"415_CR61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","volume":"24","author":"K Gaddam","year":"2010","unstructured":"Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24:532\u20137.","journal-title":"J Hum Hypertens"},{"key":"415_CR62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0194599818762383","volume":"159","author":"BT Woodson","year":"2018","unstructured":"Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N, et al. Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg (United States). 2018;159:194\u2013202.","journal-title":"Otolaryngol Head Neck Surg (United States)."},{"key":"415_CR63","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/thoraxjnl-2016-208691","volume":"71","author":"MF Pengo","year":"2016","unstructured":"Pengo MF, Xiao S, Ratneswaran C, Reed K, Shah N, Chen T, et al. Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea. Thorax. 2016;71:923\u201331.","journal-title":"Thorax"}],"container-title":["High Blood Pressure &amp; Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-020-00415-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T16:57:42Z","timestamp":1618333062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-020-00415-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s40292-020-00415-9","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Padova within the CRUI-CARE Agreement. This study was funded by: Gian Paolo Rossi: European Cooperation in Science and Technology (Grant nos. ADMIRE BM1301, ENSAT-HT 633983), Societ\u00e0 Italiana dell\u2019Ipertensione Arteriosa, FORICA (The Foundation for advanced Research In Hypertension and Cardiovascular diseases). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors do not have any conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability statements"}}]}}